News | 20 July 2012
Pfizer Inc. (PFE) won a ruling that blocks generic versions of its drug Lyrica until 2018. U.S. District Judge Gregory M. Sleet ruled yesterday that Teva Pharmaceutical Industries Ltd. (TEVA) and other generic-drug makers infringed some claims of ...
Click on the link to read the full article at Bloomberg
(This link will open in a new window)